Allurion Technologies Inc.

ALUR ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024
Assets
Cash & Equivalents $5.1M $5.4M $6.1M $12.7M $20.4M $15.4M $28.7M $19.3M
Accounts Receivable $3.5M $4.0M $4.0M $5.8M $8.3M $7.1M $9.9M $13.4M
Inventory $2.1M $2.7M $3.7M $3.8M $3.4M $3.4M $4.6M $4.8M
Total Current Assets $11.3M $12.8M $14.6M $23.5M $33.2M $27.2M $44.8M $40.3M
Property, Plant & Equipment $1.2M $1.4M $1.5M $2.0M $2.3M $2.5M $3.1M $3.3M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $14.0M $15.8M $18.1M $28.2M $38.4M $32.8M $50.7M $46.6M
Liabilities
Accounts Payable $3.1M $3.6M $2.8M $3.8M $5.0M $6.6M $10.4M $8.0M
Total Current Liabilities $37.3M $38.4M $11.6M $11.6M $15.9M $18.9M $19.2M $23.6M
Long-Term Debt $0 $0 — $28.8M $31.0M $35.7M $36.1M $41.0M
Total Liabilities $91.9M $93.0M $101.1M $92.1M $108.2M $110.8M $114.5M $117.1M
Stockholders' Equity
Retained Earnings $-257.1M $-251.0M $-244.9M $-233.0M $-223.7M $-222.2M $-212.6M $-221.3M
Total Stockholders' Equity $-77.9M $-77.2M $-82.9M $-64.0M $-69.8M $-78.0M $-64.8M $-70.6M
← Newer Page 1 of 2 Older →